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Abstract  
Aims: To investigate ex vivo peripheral neutrophil extracellular trap (NET) production and 
their subsequent degradation by plasma in chronic periodontitis patients, and periodontally 
and systemically healthy-matched controls. 
Materials and methods: Chronic periodontitis patient and control (n=40 pairs) peripheral 
blood neutrophils were stimulated for NET quantification. A subset of patients received non-
surgical periodontal therapy (n=19) and NETs were quantified 3-months later alongside 
controls. Blood plasma was collected from patients and controls to quantify plasma-induced 
NET degradation (n=19 pairs). Subsequent experiments quantified plasma concentrations of 
DNase-1, immunoglobulin G (IgG), free light chains (FLCs) and cystatin C. 
Results: No differences were observed in NET production between patients and controls. 
However, NET production decreased significantly in patient’s post-treatment. Plasma NET 
degradation was significantly lower in patients than controls, which may be due to 
significantly reduced DNase-1 levels as demonstrated, or potentially due to elevated IgG/FLC 
concentrations in patients. NET degradation post-periodontal treatment was comparable 
between patients and controls.  
Conclusions: NET production was comparable between patients and controls; however, non-
surgical therapy causes attenuated NETs. NET degradation by plasma is impaired in 
untreated chronic periodontitis, potentially increasing the chronic NET burden, which may 
enhance antimicrobial function, or conversely, increase the risk of auto-
immune/inflammatory responses. 
  
Clinical relevance 
Scientific rationale for study: Periodontitis is characterised by altered neutrophilic 
responses to periodontal pathogens, involving hyper-reactivity in reactive oxygen species 
(ROS). ROS-dependent NET release enhances antimicrobial functions, but has been linked to 
autoimmune disease. This study aimed to characterise NET release and removal in 
periodontitis. 
Principal findings: No difference in NET quantification was observed pre-treatment, 
compared with healthy controls, but successful periodontal treatment reduced NET 
production. However, plasma-derived NET degradation was decreased in patients compared 
with controls. 
Practical implications: Excess NET production or retention within tissues may serve as an 
important antimicrobial strategy in untreated periodontitis; conversely this may contribute to 
the pathogenesis of periodontitis via autoimmune responses. 
 
Introduction  
Periodontitis is a chronic inflammatory disease, initiated by dysbiosis within the subgingival 
plaque biofilm and progressed by a damaging dysregulation of the hosts’ inflammatory-
immune response (Hajishengallis, 2014). This results in chronic, destructive and non-
resolving inflammation of the periodontal tissues (Bascones-Martínez and Figuero-Ruiz, 
2003). In addition to periodontal tissue destruction, periodontitis is associated with other 
inflammatory diseases of ageing, such as diabetes mellitus and rheumatoid arthritis (Chapple 
and Genco, 2013, de Pablo et al., 2009). 
Neutrophils are the principal inflammatory cell in active periodontal lesions. Peripheral blood 
neutrophils (PBN) isolated from periodontitis patients are hyperactive, with regard to reactive 
oxygen species (ROS) generation in the absence of exogenous stimulation, and hyper-
reactive, exhibiting increased ROS production when subjected to stimulation (Matthews et 
al., 2007a, Matthews et al., 2007b). The underlying mechanisms responsible for this 
neutrophil hyper-responsivity remain to be elucidated, however there are indications for both 
constitutive abnormalities in periodontitis neutrophils, and also evidence for neutrophil 
priming by serum-derived cytokines (Dias et al., 2011, Ling et al., 2015). Resultant 
extracellular ROS release contributes to oxidative stress and downstream host collateral 
tissue damage (Chapple and Matthews, 2007). 
Neutrophils also have alternative defence mechanisms at their disposal, including the 
production of neutrophil extracellular traps (NETs). NETs constitute a highly conserved anti-
microbial strategy that results from inflammatory-immune cells releasing their de-condensed 
nuclear chromatin (DNA) into the extracellular space, where they immobilise and kill 
pathogens (Brinkmann et al., 2004). NET structures are reportedly present in plaque biofilms 
(Hirschfeld et al., 2015), as well as in the gingival pocket epithelium and in pus from the 
gingival crevice (Vitkov et al., 2010). We have also demonstrated NET-like structures within 
periodontally inflamed tissues (Cooper et al., 2013) and proposed that in addition to NETs’ 
initially beneficial role, abnormal NET release and/or accumulation within periodontal tissues 
may trigger auto-inflammatory responses and thus a destructive inflammatory-immune 
response (Cooper et al., 2013, de Pablo et al., 2013). Notably NET production has been 
associated with the pathogenesis of several other autoimmune diseases, such as systemic 
lupus erythematosus (SLE) (Hakkim et al., 2010, Leffler et al., 2012). 
NET release requires NADPH-oxidase activation, resulting in the sequential production of 
superoxide and hydrogen peroxide, which is subsequently converted by myeloperoxidase 
(MPO) to hypochlorous acid (HOCl) (Fuchs et al., 2007, Palmer et al., 2012). There is 
currently no literature investigating NET production in chronic periodontitis patients. Given 
that periodontal PBNs demonstrate ROS hyper-responsivity, it is important to determine NET 
production in periodontitis patients. 
Specific mechanisms contributing to NET clearance from tissues remain to be fully 
elucidated; however reports indicate that NETs are degraded by host and bacterial DNases 
(Meng et al., 2012). Recently it has been reported that the DNase-containing sera of 
systemically healthy individuals are capable of degrading NETs, however this mechanism is 
compromised in subsets of patients with SLE (Hakkim et al., 2010, Leffler et al., 2012). 
Impaired NET degradation is believed to result from formation of a physical barrier, for 
example, from elevated levels of anti-NET immunoglobulins, which prevent enzymatic NET 
degradation (Hakkim et al., 2010).  
Notably, immunoglobulins comprise 2 heavy and 2 light chains (either kappa or lambda), and 
during their normal synthesis by B cells, light chains are produced in excess and released into 
circulation as free light chains (FLCs) (Solomon, 1985). FLC overproduction has been 
reported in several chronic diseases, which may be the result of chronic immune stimulation 
(Brebner and Stockley, 2013). However, the association between FLCs and NET degradation 
has not been investigated previously. 
De Pablo et al., (2009) demonstrated that periodontitis patients produce serum autoantibodies 
in response to citrullinated and uncitrullinated peptides. Thus, whilst increased NET 
production or retention within periodontal tissues may serve to prolong NET antimicrobial 
function, NET-derived citrullinated peptides may concomitantly facilitate autoantibody 
generation and collateral host periodontal tissue damage (Cooper et al., 2013, White et al., 
2016).  
The purpose of this study, therefore, was to determine whether NET release is altered in 
chronic periodontitis patients, compared with periodontally healthy age- and gender-matched 
controls. In a subset of patients, NET release was quantified following successful periodontal 
therapy and compared with the same healthy controls. Additionally, NET degradation by 
patient and control plasma pre- and post-treatment was investigated. Subsequent experiments 
sought to establish whether an immunoglobulin or immunoglobulin-FLC barrier prevents the 
enzymatic removal of NETs in periodontitis patients. This analysis involved the 
quantification of immunoglobulin G (IgG) and FLCs in patient and control plasma samples. 
Materials and Methods 
Study populations: Volunteers were diagnosed with chronic periodontitis at Specialist 
Periodontal Centres in Birmingham, UK (n=20) and Thessaloniki, Greece (n=20). 
Periodontitis was defined as the presence of at least two non-adjacent sites with probing 
pocket depths >4mm, along with radiographic bone loss >30% of the root length in 
accordance with the consensus criteria of the European Federation of Periodontology (Tonetti 
and Claffey, 2005). Healthy controls were recruited from dental staff at Birmingham, UK and 
Thessaloniki, Greece. All volunteers were age- (+5 yrs) and gender-matched to their 
corresponding patient pair. All participants were systemically healthy, had not smoked for at 
least 10 years, were not pregnant and were not taking any medication that may influence 
periodontal health. Ethical approval for the study was obtained from West Midlands Research 
Ethics Committee, UK (10/H1208/48), and the School of Dentistry ethical committee at 
Aristotle University, Thessaloniki, Greece (317/23/1/2013). 
Non-surgical periodontal therapy was provided in Birmingham, UK, which consisted of 
scaling and root surface debridement of all periodontal pockets >4mm, performed under local 
anaesthesia on a quadrant-by-quadrant basis within a maximum of 4 weeks.  
NET release was determined at both centres in periodontitis patients and controls prior to 
periodontal treatment using the same laboratory protocols and reagents. To ensure 
consistency of approach and calibration of centres DS (Thessaloniki) visited and trained with 
PW (Birmingham) in all NET protocols. Analyses of post-treatment NET release, NET 
degradation, plasma IgG, FLC and Cystatin C concentrations were only performed on 
samples from Birmingham volunteers for logistical reasons.  
Collection of peripheral blood and neutrophil isolation: Venous blood was collected in 
lithium heparin vacutainers from patients and healthy controls in parallel. Neutrophils were 
isolated as described previously (Matthews et al., 2007a, Oh et al., 2008).  In brief, 
neutrophils were isolated by centrifugation of venous blood over discontinuous Percoll 
density gradients. Following centrifugation, the neutrophil layer was aspirated and added to 
lysis buffer to remove unwanted erythrocytes. The cells were subjected to a second lysis 
buffer wash, prior to a final PBS wash. The supernatants were discarded and the cells were 
re-suspended in PBS prior to counting. Cell viability and purity were confirmed by trypan 
blue exclusion and flow cytometry, respectively, and was typically >98%. 
Collection of plasma: Venous blood was collected in lithium heparin vacutainers from 
patients and controls. Plasma was isolated by centrifugation (1,000 rcf for 30 min at 4°C), 
aliquoted into cryotubes (500 µl in each) and stored at -80°C.   
Quantification of NETs: NET production was quantified as previously described (Palmer et 
al., 2012).  Briefly, neutrophils were re-suspended in RPMI-1640 and added to a pre-blocked 
96-well microplate (1 x 10
5 
in 150 µl per well). Following a 30 min baseline incubation 
period (37°C), selected wells were stimulated with 50 nM phorbol myristate acetate (PMA) 
or 0.75 mM HOCl. Cells were incubated for 3 hours (37°C, 5% CO2) and NET DNA was 
subsequently digested by the addition of micrococcal nuclease (MNase) (15 µl at 1 unit/ml) 
for 15 min. Cells were pelleted (10 min at 1,800 rcf) and the supernatant (150 µl) transferred 
to a black microplate prior to the addition of Sytox green (Life Technologies; 15 μl, 10μM). 
Fluorescence was read in arbitrary fluorescence units (AFU) using a fluorometer 
(Birmingham - Twinkle LB970, Berthold Technologies; Thessaloniki - Victor X5, 
PerkinElmer Inc. USA). NET production by patients and controls was compared by 
fluorescence microscopy, whereby isolated neutrophils (1x10
5
) were added to clear 24-well 
plates in 260 µl RPMI-1640 and stimulated as previously described. Following stimulation, 
cells were incubated for 3 hours (37°C, 5% CO2), after which, 25 μl of 10 μM Sytox green 
was added to each well and NETs visualised (epi-fluorescent microscope, Nikon Eclipse 
TE300). A calibration curve was generated by quantifying Sytox green stained-calf thymus 
DNA to enable data normalisation between the centres. This approach provided interpolated 
values for NET production in µg/ml.  
Quantification of NET degradation by plasma: Neutrophils were isolated from a 
systemically and periodontally healthy individual and stimulated for NETs with HOCl as 
previously described (Palmer et al., 2012).  Post-NET release, previously isolated plasma 
from periodontitis patients and matched controls were defrosted and diluted to 10% in PBS 
(Hakkim et al., 2010).  Plasma was added to wells in 50 µl aliquots and incubated for 3 hours 
(37°C, 5% CO2). Selected wells containing NETs were treated with 1 unit/ml MNase for 10 
min to act as a positive control for NET degradation, and were considered as the “100% NET 
degradation” standard.  After 3 hours incubation, plates were centrifuged (10 min at 1800 rcf) 
and the number of NETs liberated into the supernatant, as a result of incubation with plasma, 
were quantified as described previously.  
Quantification of plasma DNase-1, IgG subclasses 1–4, FLCs and cystatin C 
DNase-I levels were measured in previously collected patient and control plasma samples 
(n=19 pairs; pre-treatment only) using a fluorescence-based DNase detection kit (Jena 
Bioscience (Jena, Germany), in which plasma (10 µl) was incubated with a fluorescent 
DNase probe. After incubation (30 min at 37°C, 5% CO2), fluorescence was detected using a 
fluorometer under the same conditions as for NET quantification. 
 
Previously collected plasma samples were analysed by The Binding Site Group Ltd 
(Birmingham, UK).  IgG subclasses 1–4 were quantified using the SPAPLUS® analyser, in 
addition FLC kappa and FLC lambda concentrations were quantified using the 
SPAPLUS
®
 turbidimeter (Freelite, The Binding Site Group Ltd). Cystatin C levels were also 
uantified using the SPAPLUS
®
 assay. Cystatin C levels were measured to determine whether 
excessive plasma FLCs in periodontitis patients might have resulted from impaired renal FLC 
clearance.  
Data analysis: Statistical analyses in GraphPad Prism 5 included NET production pre- and 
post-treatment, NET degradation, and IgG and FLC quantification using Mann-Whitney tests 
(unless otherwise stated). 
 
Results 
Clinical measures including longitudinal changes following periodontal treatment. 
Clinical measures for the chronic periodontitis patients and matched controls recruited in the 
UK and Greece are presented in Table 1. All clinical measures of periodontal disease were 
significantly reduced at the post-treatment review (p<0.05), consistent with the literature and 
with patient levels becoming comparable to those of controls (Ling et al., 2015, Ling et al., 
2016). 
Periodontitis is not associated with elevated NET production by peripheral blood 
neutrophils.  No significant difference was measured in extracellular DNA release from 
PBNs in patients compared with controls. This was evident in both patient populations 
(Birmingham, UK – n=20; Thessaloniki, Greece – n=20) for PBS-treated (negative control, 
p=0.89) as well as PMA- (p=0.52) and HOCl-stimulated (p=0.73) PBNs (Figure 1a). 
Comparable NET production between patients and controls was observed in both patient 
populations when analysed separately, as well as when pooled. Similarly, representative 
micrographs of sytox-stained DNA showed the characteristic network of extracellular DNA 
strands, with no qualitative differences in NET morphology between patients and controls 
(representative images n=3) (Figure 1b).   
NET production significantly decreased following successful periodontal treatment. In a 
subset of patients from Birmingham, UK, NET assays were repeated between 2-months 
(minimum) and 3-months (maximum) following successful periodontal treatment and 
assayed in parallel with their healthy controls (n=19 pairs). To account for day-to-day 
neutrophil variability pre- and post-treatment, NET production by healthy controls was 
expressed as a ratio with that of patients (assayed simultaneously). NET production in 
patients neutrophils for PBS- as well as PMA- and HOCl-stimulated cells significantly 
decreased relative to healthy controls as a result of treatment (Mann-Whitney **p=0.03, 
**p=0.008, *p=0.043 for PBS, PMA and HOCl, respectively) (Figure 2).  
Plasma-derived NET degradation is significantly reduced in periodontitis patients, but 
restored following successful treatment. There was a significant difference in NET 
degradation between patient and control plasma (n=19 pairs; Mann-Whitney, ****p=0.0001), 
with plasma derived from patients degrading significantly fewer NETs. It was noted that 
patients exhibited a larger distribution of NET degradation compared with controls (Figure 
4a). Plasma degradation assays were repeated between 2-months (minimum) and 3-months 
(maximum) following successful treatment and assayed in parallel with the same healthy 
controls (n=19 pairs). Plasma-derived NET degradation in patients was comparable with that 
of their healthy counterparts (Mann-Whitney, p=0.124). However, the range of patient NET 
degradation still exhibited greater heterogeneity compared with healthy controls (Figure 3).  
Comparison of plasma DNase-1, IgG, FLC and cystatin C concentrations in 
periodontitis patients and matched periodontally healthy controls.  
DNase-I concentrations measured in pre-treatment patient and control plasma samples (n=19 
pairs) were significantly lower in patient samples compared with controls (Mann-Whitney, 
p=0.04) (Figure 4). 
Protein turbidimetric analysis demonstrated that plasma IgG concentrations were consistently 
higher in patients, compared with controls. This was statistically significant for IgG subclass 
2 pre-treatment (Mann-Whitney *p=0.038), IgG subclass 3 pre- and post-treatment (Mann-
Whitney ***p=0.0007, **p=0.0042 pre and post-treatment, respectively), and IgG subclass 4 
post-treatment (Mann-Whitney *p=0.042) (Figure 5).  
FLC concentrations were also consistently higher in patients compared with controls. This 
was statistically significant for FLC kappa pre- and post-treatment (Mann-Whitney 
*p=0.049, *p=0.048 pre- and post-treatment, respectively), the kappa/lambda ratio pre-
treatment (Mann-Whitney *p=0.047), and summated FLC levels pre-treatment (Mann-
Whitney *p=0.032 (Figure 6). 
There was however no significant difference in cystatin C levels (mg/litre) between control 
and patient plasma samples both pre- and post-treatment (Mann-Whitney p=0.74, p=0.82 
pre- and post-treatment, respectively, n=19 matched pairs; data not shown), demonstrating no 
impairment of renal FLC clearance.  
 
Discussion 
Neutrophils play a pivotal role within the periodontal lesion in response to colonisation by 
pathogenic bacteria (Miyasaki, 1991, Schenkein, 2006). However, it is widely accepted that a 
dysregulated neutrophilic response contributes to tissue destruction in chronic periodontitis 
(Van Dyke et al., 1993). Neutrophil hyper-responsivity with regard to ROS production is 
likely to contribute to the degradation of periodontal tissues, and given the recently reported 
deficiencies in neutrophil chemotactic accuracy in periodontitis patients (Roberts et al., 
2015), may increase neutrophil tissue transit times and consequently cause collateral tissue 
damage (Matthews et al., 2007a, Matthews et al., 2007b, Waddington et al., 2000).  
The putative role of NETs is to immobilise and kill pathogens by co-localising with, and 
tethering the microorganisms. Currently, it is unknown whether NETs have the capacity to 
kill all bacterial species, and it is postulated that NETs may only immobilise bacteria (Beiter 
et al., 2006, Menegazzi et al., 2012). It is recognised that NET production relies upon ROS, 
specifically NADPH-oxidase activation and the subsequent production of hydrogen peroxide 
(Fuchs et al., 2007). Recent reports have confirmed this mechanism and also identified the 
involvement of MPO in NET formation (Kirchner et al., 2012, Metzler et al., 2011, 
Papayannopoulos et al., 2010, Palmer et al., 2012). Thus, we hypothesised that ROS 
hyperactivity and -reactivity in periodontitis patient neutrophils would translate to elevated 
NETs.  
NETs have previously been shown to exist in purulent exudate from periodontal pockets 
(Vitkov et al., 2009, 2010), and this is corroborated by recent findings that demonstrate 
neutrophils infiltrate the dental plaque and subsequently release NET structures (Hirschfeld et 
al., 2015). Further support for the presence of NET production in periodontitis is that 
periodontal pockets reportedly provide an appropriate environment for ROS production, by 
the provision of sufficient oxygen tension and pH (Mettraux et al., 1984, Eggert et al., 1991). 
However, alternative NADPH-oxidase-independent pathways leading to NET production 
have also been reported (Parker et al., 2012, Pilsczek et al., 2010).   
No differences, however, were measured in PBN NET production between patients and 
controls. A potential explanation could relate to a recently reported self-protective 
mechanism within glutathione deficient periodontitis neutrophils, involving re-siting of 
certain NADPH-oxidase components to outer cell membrane lipid rafts (Dias et al., 2013). 
This mechanism was reported in PBN from periodontitis patients following the discovery that 
these cells were oxidatively stressed, as evidenced by an altered redox state. Thus, when 
challenged by a further stimulus the periodontitis patient neutrophils release superoxide 
extracellularly to avoid further oxidative stress and risk of cell necrosis. It is therefore 
plausible that re-direction of ROS to the extracellular space may limit the intracellular ROS 
levels available for NET production (Dias et al., 2013, Guichard et al., 2005).  
To investigate NET production further, their quantification post-treatment was determined in 
a sub-set of periodontitis patients’ neutrophils and compared with their respective healthy 
controls (n=19 pairs). A significant decrease in NET release was evident in periodontitis 
patient neutrophils following successful therapy. Previous findings have demonstrated that 
successful non-surgical treatment results in a reduction in neutrophil ROS hyper-reactivity 
following FcγR-stimulation, unlike baseline ROS hyperactivity, which did not normalise as a 
result of treatment (Matthews et al., 2007a). It has been proposed that priming of PBNs by 
cytokines within blood plasma may contribute to the FcγR-mediated neutrophil hyper-
reactive phenotype observed in periodontitis, which is reversible with effective treatment 
(Dias et al., 2011). Reduced neutrophil priming and ROS production following successful 
treatment may represent one explanation for the reduced post-therapy NET production. 
NET degradation by chronic periodontitis patients’ plasma was also quantified, and 
demonstrated that NET degradation was significantly lower in a subset of chronic 
periodontitis patients pre-treatment, relative to controls. To our knowledge this is the first 
report evaluating NET removal in periodontitis patients. Mechanisms involved in NET 
clearance remain to be thoroughly elucidated; however reports indicate that host-derived 
DNases degrade NETs to affect their removal from tissues where high levels of citrullination 
may potentiate autoimmune responses against citrullinated proteins. Attenuated NET 
degradation has been reported in SLE, and has been suggested to result from either the 
presence of DNase-1 inhibitors in patient serum or from some form of physical molecular 
barrier that prevents DNase-1 access to cleavage sites on the NET backbone (Hakkim et al., 
2010, Leffler et al., 2012).  
We report, for the first time, lower plasma DNase-1 concentrations in patients compared with 
controls, as well as elevated Kappa FLCs, Kappa/Lambda ratio’s and summated FLCs, which 
may individually or in combination explain the decreased NET degradation measured in 
patients. Notably, cystatin C levels were comparable between patients and controls, 
indicating that elevated FLCs are not the result of insufficient renal FLC clearance, but likely 
the result of increased FLC production by B cells, which are the dominant lymphocyte in 
active periodontitis lesions. Increased circulating IgG and FLCs in patients may translate to 
IgG and/or FLC binding to NET structures, given the significantly elevated serum auto-
antibody levels to citrullinated histones of DNA already reported by our group in 
periodontitis patients (dePablo et al. 2013). Such immunoglobulin binding may either tether 
bacteria to NETs, facilitating their destruction, or conversely may provide a physical barrier 
that prevents the degradation of NETs by DNase-1, as demonstrated in SLE (Leffler et al. 
2013). However, further extensive studies into the role of IgGs and FLCs in NET degradation 
are warranted and currently underway to further elucidate the mechanisms of decreased NET 
degradation in periodontitis.   
Attenuated NET removal may constitute an antimicrobial host response during infection, as 
NETs can prevent microbial dissemination by entrapping a range of periodontal bacteria 
(Brinkman et al., 2004). The host’s ability to adjust the extracellular “life-span” of NETs in 
response to the microbial biofilm may also explain why no differences in PBN NET release 
were observed between patients and controls. Conversely, an accumulation of NETs as a 
result of impaired clearance may impact deleteriously upon the host, as it has been reported 
that NETs provide a source of autoantigens, which may trigger autoimmune responses and 
facilitate disease progression (Krysko et al., 2006, Lande et al., 2011, Spengler et al., 2015).  
It is also possible that NET production in periodontal tissues may serve as a plausible 
mechanism for the production of anti-citrullinated protein antibodies (ACPA) following a 
break in immune tolerance to NET-derived citrullinated (de Pablo et al., 2009), and this 
process may be exacerbated if NETs are not removed in a timely manner. Indeed this is one 
plausible explanation for the higher prevalence of ACPAs and higher serum ACPA titres in 
periodontitis patients compared with controls (de Pablo et al., 2013). 
 
Conclusions 
The reported studies have demonstrated that NET production is not significantly different 
between patients and controls, however patient NET production decreased following 
successful periodontal therapy. Notably, in a subset of patients in which NET degradation by 
plasma was investigated, patients were less able to degrade NETs, compared with controls. 
The reported decreased plasma DNase-levels may explain, in part, the impeded NET 
degradation observed in patients. Another plausible mechanism may be the reported 
increased plasma IgG and FLC levels, potentially generating a physical barrier to prevent 
NET removal in patients. Further experiments are warranted to confirm these hypotheses. 
Notably, NET degradation assays post-treatment demonstrated comparable results between 
patients and controls. Taken together, the data provide new insights into the myriad of 
abnormal neutrophil behaviours displayed during the pathogenesis of periodontitis, 
specifically in relation to NET production and clearance.   
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Figure Legends 
Table 1: Clinical measures of chronic periodontitis patients & matched healthy controls 
recruited in the UK (baseline n=20; review n=19) & Greece (baseline n=20).  
Volunteer ages (at time of sampling) were compared by Mann-Whitney test (no significant 
differences within or between groups). Probing pocket depths were compared by one-way 
ANOVA followed by Tukey-Kramer test. All other comparisons were performed using 
Kruskal-Wallis test followed by Dunn's test. Clinical data for the UK volunteer cohorts have 
been published previously (Ling et al., 2015) 
*
probing pocket depth ≥4mm, gingival index, plaque index & post-treatment review data 
were collected solely from the UK cohort. 
#
comparison with corresponding controls (p<0.05). 
$
comparison with chronic periodontitis before treatment (p<0.05). 
Abbreviations: NR, not reported; SD, standard deviation; UK, United Kingdom. 
Figure 1: NET production in pre-treatment periodontitis patients and healthy controls  
(a) Pre-treatment NET production was quantified fluorometrically by Sytox Green staining 
following a 3-hour incubation period after neutrophil stimulation (UK and Greek cohort). (i) 
PBS (unstimulated negative control), (ii) PMA (50 nM) and (iii) HOCl (0.75mM). Statistical 
significance calculated using Mann-Whitney tests. Data are presented as AFU (arbitrary 
fluorescence units) and expressed as mean ± SEM (n=20 pairs in quadruplicate). (b) 
Fluorescence microscopy of NETs from patients and controls pre-treatment. NETs were 
visualised at x20 magnification following Sytox green staining in response to PBS 
(unstimulated negative control), PMA (50 nM) and HOCl (0.75 mM) exposure for 3 hours. 
White arrows indicate NET strands. Images are representative of 2 experiments performed in 
subjects recruited to Birmingham Dental Hospital, UK, and were performed in triplicate. 
Scale bars represent 100µm.  
 
Figure 2: Pre- and post-treatment NET production by periodontitis patients and 
healthy controls. 
NET production pre- and post-treatment expressed as a ratio of patients to matched controls 
(y-axis). (a) PBS (unstimulated negative control), (b) PMA (50 nM) and (c) HOCl (0.75 
mM). Data are presented as AFU (arbitrary fluorescence units) (n=19 pairs in quadruplicate). 
 
Figure 3: NET degradation by plasma from periodontitis patients and controls pre- and 
post-periodontal treatment  
HOCl-stimulated (0.75 nM) neutrophils were incubated with 10% plasma from periodontitis 
patients and healthy age/gender matched controls for 3 hours. NETs were quantified 
fluorometrically using the Sytox green assay. Percentage NET degradation was calculated 
based on a 1 U/ml MNase following 15 min digestion that was used to represent the 100% 
standard. (a) A significant difference between patient and control NET degradation was 
observed pre-treatment, however this difference was absent when the assay was repeated 
post-treatment (b). Data expressed as mean ± SEM (n=19 matched pairs).   
 
Figure 4: Plasma DNase-1 concentrations in periodontitis patients and controls 
DNase-I levels were measured from pre-treated patient plasma samples alongside healthy-
matched controls. DNase-I levels were quantified fluorometrically following 30 min 
incubation with a DNase detection probe. Significantly reduced DNase-I levels were detected 
in patient samples relative to control. Data expressed as means ± SEM (n=19 matched pairs). 
 
 
Figure 5: Plasma IgG concentrations in periodontitis patients and controls 
IgG subclasses 1-4 concentrations were measured by protein turbidimetric analysis in plasma 
samples from periodontitis patients and healthy matched controls pre- and post-treatment. (a) 
IgG subclass 1, (b) IgG subclass 2, (c) IgG subclass 3, (d) IgG subclass 4. Data expressed as 
means ± SEM (n=19 matched pairs).   
 
Figure 6: Plasma FLC concentrations in periodontitis patients and controls  
(a) Free kappa light chains; (b) free lambda light chains; (c) the kappa/lambda ratio and (d) 
summated FLCs were measured by protein turbidimetric analysis in plasma samples from 
periodontitis patients and healthy matched controls pre- and post-treatment. Data expressed 
as means ± SEM (n=19 matched pairs).   
  
Table 1 
 
Clinical measures* 
Chronic periodontitis patients 
Controls 
Baseline Review 
Age, years, mean+SD (range) 
UK 46+8 (37-61) 46+8 (32-62) 
Greece 52+8 (36-70) NR 50+11(35-82) 
Probing pocket depth, mm, mean+SD 
UK 3.0+0.8# 2.1+0.5$ 1.5+0.4 
Greece 3.9+0.8# NR 1.8+0.7 
No. probing pocket depths >4mm, 
median (range) 
UK 27 (5-91)# 7 (0-52)$ 0 (0-4) 
% sites bleeding on probing, median 
(range) 
UK 43 (16-87)# 14 (3-35)$ 2 (0-39) 
Greece 65 (50-100)# NR 3 (0-23) 
Gingival index, median (range) UK 2 (1-3)# 1 (0-1)$ 1 (0-1) 
Plaque index, median (range) UK 2 (1-3)# 1 (0-2)$ 1 (0-2) 
Volunteer ages (at time of sampling) were compared by Mann-Whitney test (no significant differences within or 
between groups). Probing pocket depths were compared by one-way ANOVA followed by Tukey-Kramer test. 
All other comparisons were performed using Kruskal-Wallis test followed by Dunn's test. Clinical data for the 
UK volunteer cohorts have been published previously (Ling et al., 2015) 
*probing pocket depth ≥4mm, gingival index, plaque index & post-treatment review data were collected solely 
from the UK cohort. 
#comparison with corresponding controls (p<0.05). 
$comparison with chronic periodontitis before treatment (p<0.05). 
Abbreviations: NR, not reported; SD, standard deviation; UK, United Kingdom. 
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